脓毒症中乳酸动脉与静脉一致性:一项前瞻性观察研究
该研究为单中心前瞻性观察队列研究,纳入英国 NHS 急诊科 304 例脓毒症患者,同时配对测量外周静脉乳酸(PV-LACT)与动脉乳酸(A-LACT)。Bland-Altman 分析显示平均差值(PV-LACT−A-LACT)为 0.4 mmol/l(95%CI 0.37–0.45),95% 一致性界限为 −0.4(95%CI −0.45 至 −0.32)至 1.2(95%CI 1.14–1.27)。PV-LACT≥2 mmol/l 预测 A-LACT≥2 mmol/l 的敏感度为 100%(95%CI 89–100%),特异度为 83%(95%CI 77–87%)。作者认为这是目前比较两种测量的最大研究,显示良好临床一致性,推荐在脓毒症患者常规筛查中使用 PV-LACT,PV-LACT<2 mmol/l 可预测 A-LACT<2 mmol/l。
要点
- 在急诊脓毒症患者中,PV-LACT 与 A-LACT 平均差值为 0.4 mmol/l(95%CI 0.37–0.45),95% 一致性界限为 −0.4 至 1.2 mmol/l。
- PV-LACT≥2 mmol/l 预测 A-LACT≥2 mmol/l 的敏感度为 100%(95%CI 89–100%),特异度为 83%(95%CI 77–87%)。
- PV-LACT<2 mmol/l 可预测 A-LACT<2 mmol/l,作者推荐用 PV-LACT 对脓毒症患者进行常规筛查。
- 作者认为这是目前比较两种测量的最大研究,显示良好临床一致性。
适用人群与场景
- 英国 NHS 急诊科(每年约 110 000 例成人就诊)就诊的脓毒症患者,共 304 例签署知情同意者。
诊断标准与关键阈值
- PV-LACT≥2 mmol/l 预测 A-LACT≥2 mmol/l,敏感度 100%(95%CI 89–100%),特异度 83%(95%CI 77–87%)。
- PV-LACT<2 mmol/l 可预测 A-LACT<2 mmol/l。
研究设计与关键结果
- 单中心前瞻性观察队列研究,纳入英国 NHS 急诊科 304 例脓毒症患者,配对测量 PV-LACT 与 A-LACT。
- Bland-Altman 分析:平均差值(PV-LACT−A-LACT)为 0.4 mmol/l(95%CI 0.37–0.45),95% 一致性界限为 −0.4(95%CI −0.45 至 −0.32)至 1.2(95%CI 1.14–1.27)。
- PV-LACT≥2 mmol/l 预测 A-LACT≥2 mmol/l 的敏感度为 100%(95%CI 89–100%),特异度为 83%(95%CI 77–87%)。
- 作者认为这是目前比较两种测量的最大研究,显示良好临床一致性,推荐在脓毒症患者常规筛查中使用 PV-LACT。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐在脓毒症患者常规筛查中使用 PV-LACT。
- 作者认为 PV-LACT<2 mmol/l 可预测 A-LACT<2 mmol/l。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a common condition in the emergency department (ED). Lactate measurement is an important part of management: arterial lactate (A-LACT) measurement is the gold standard. There is increasing use of peripheral venous lactate (PV-LACT); however, there is little research supporting the interchangeability of the two measures.If PV-LACT has good agreement with A-LACT, it would significantly reduce patient discomfort and the risks of arterial sampling for a large group of acutely unwell patients, while allowing faster and wider screening, with potential reduced costs to the healthcare system.
OBJECTIVE: The aim of this study is to determine the agreement between PV-LACT and A-LACT in septic patients attending the ED.
METHODS: We carried out a prospective observational cohort study of 304 consented patients presenting with sepsis to a single UK NHS ED (110 000 adult attendances annually) taking paired PV-LACT and A-LACT. Bland-Altman analysis was carried out to determine agreement. Receiver operating characteristic curves and 2×2 tables were constructed to explore the predictive value of PV-LACT for A-LACT.
RESULTS: The mean difference (PV-LACT-A-LACT) is 0.4 mmol/l [95% confidence interval (CI): 0.37-0.45], with 95% limits of agreement from -0.4 (95% CI: -0.45 to -0.32) to 1.2 (95% CI: 1.14-1.27). A PV-LACT of at least 2 mmol/l predicts an A-LACT of at least 2 with 100% sensitivity (95% CI: 89-100%) and 83% specificity (95% CI: 77-87%).
CONCLUSION: This study is the largest comparing the two measurements, and shows good clinical agreement. We recommend using PV-LACT in the routine screening of septic patients. A PV-LACT less than 2 mmol/l is predictive of an A-LACT less than 2 mmol/l.
参考来源
- Datta D, Grahamslaw J, Gray AJ, et al. Lactate - Arterial and Venous Agreement in Sepsis: a prospective observational study. Eur J Emerg Med. 2018. PMID: 27926537. doi:10.1097/MEJ.0000000000000437
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。